|
US4393066A
(en)
*
|
1981-06-05 |
1983-07-12 |
Garrett David M |
Method for treatment of herpetic lesions
|
|
US4499064A
(en)
*
|
1982-06-03 |
1985-02-12 |
Clayton Foundation For Research |
Assessment of nutritional status of individuals
|
|
US4575498A
(en)
*
|
1983-07-21 |
1986-03-11 |
Duke University |
Method for restoring depleted purine nucleotide pools
|
|
US4628052A
(en)
*
|
1985-05-28 |
1986-12-09 |
Peat Raymond F |
Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities
|
|
CH673459A5
(https=)
*
|
1987-05-15 |
1990-03-15 |
Eprova Ag |
|
|
ES2043897T3
(es)
*
|
1988-01-28 |
1994-01-01 |
Koeltringer Peter |
Preparado de combinacion, en especial para el tratamiento de enfermedades de las celulas nerviosas.
|
|
FR2631828B1
(fr)
*
|
1988-05-27 |
1994-05-20 |
Spiral Recherche Developpement |
Utilisation d'une substance folinique en tant qu'agent antiagregant plaquettaire
|
|
US4931441A
(en)
*
|
1988-11-09 |
1990-06-05 |
Luitpold Pharmaceuticals, Inc. |
Stabilized aqueous leucovorin calcium compositions
|
|
US4920115A
(en)
*
|
1988-12-28 |
1990-04-24 |
Virginia Commonwealth University |
Method of lowering LDL cholesterol in blood
|
|
US5407684A
(en)
*
|
1988-12-30 |
1995-04-18 |
Virginia Commonwealth University |
Use of DHEA as a medicinal
|
|
US5077284A
(en)
*
|
1988-12-30 |
1991-12-31 |
Loria Roger M |
Use of dehydroepiandrosterone to improve immune response
|
|
IT1229517B
(it)
*
|
1989-01-31 |
1991-09-03 |
Bioresearch Spa |
Impiego di acido 5-metiltetraidrofolico, di acido 5 formiltetraidrofolico, e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato adatte ad essere impiegate nella terapia dei disordini depressivi e composizioni farmaceutiche relative.
|
|
IT1229203B
(it)
*
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
NL8901432A
(nl)
*
|
1989-06-06 |
1991-01-02 |
Pharmachemie Bv |
Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan.
|
|
US4985443A
(en)
*
|
1989-08-04 |
1991-01-15 |
Montes Leopoldo F |
Method and composition for treating vitiligo
|
|
US5173488A
(en)
*
|
1989-08-21 |
1992-12-22 |
American Cyanamid Company |
Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method
|
|
US5270305A
(en)
*
|
1989-09-08 |
1993-12-14 |
Glaxo Group Limited |
Medicaments
|
|
US5162198A
(en)
*
|
1991-02-08 |
1992-11-10 |
Virginia Commonwealth University |
Method of using dehydroepiandrosterone and dehydroepiandrosterone-sulfate as inhibitors of thrombuxane production and platelet aggregation
|
|
US5110810A
(en)
*
|
1991-02-08 |
1992-05-05 |
Virginia Commonwealth University |
Method of using dehydroepiandrosterone and dehydroepiandrosterone-sulfate as inhibitors of platelet aggregation
|
|
US5266312A
(en)
*
|
1992-01-07 |
1993-11-30 |
National Jewis Center For Immunology And Respiratory Medicine |
Method for treating a steroid resistant condition via administration of gamma interferon
|
|
JPH07504198A
(ja)
*
|
1992-02-24 |
1995-05-11 |
イースト カロライナ ユニバーシティ |
デヒドロエピアンドロステロンおよびその類縁体を用いる処置によって発癌を抑制する方法
|
|
US6093706A
(en)
*
|
1992-03-04 |
2000-07-25 |
Bioresponse, L.L.C. |
Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders
|
|
MX9301903A
(es)
*
|
1992-04-02 |
1994-08-31 |
Smithkline Beecham Corp |
Compuestos.
|
|
WO1993019748A1
(en)
*
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor
|
|
EP0636026B1
(en)
*
|
1992-04-02 |
2001-12-05 |
Smithkline Beecham Corporation |
Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
|
|
HU225869B1
(en)
*
|
1992-04-02 |
2007-11-28 |
Smithkline Beecham Corp |
Compounds with antiallergic and antiinflammatory activity and pharmaceutical compns. contg. them
|
|
US5922701A
(en)
*
|
1992-05-01 |
1999-07-13 |
University Of Utah Research Foundation |
Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
|
|
US5686438A
(en)
*
|
1993-03-09 |
1997-11-11 |
University Of Utah Research Foundation |
Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
|
|
AU5855794A
(en)
*
|
1993-01-19 |
1994-08-15 |
Endorecherche Inc. |
Therapeutic uses and delivery systems of dehydroepiandrosterone
|
|
KR960700728A
(ko)
*
|
1993-03-09 |
1996-02-24 |
토마스 메이져 |
진행성 조직 괴사, 재관류 손상, 세균 전이 및 성인 호흡 장애 증후군의 예방 방법(Methods for Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation and Adult Respiratory Distress Syndrome)
|
|
US5635496A
(en)
*
|
1993-03-09 |
1997-06-03 |
University Of Utah Research Foundation |
Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
|
|
US5811418A
(en)
*
|
1993-03-09 |
1998-09-22 |
University Of Utah Research Foundation |
Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
|
|
US5846963A
(en)
*
|
1995-06-07 |
1998-12-08 |
University Of Utah Research Foundation |
Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
|
|
US5407927A
(en)
*
|
1993-04-16 |
1995-04-18 |
The Regents Of The University Of California |
Treatment of mild depression and restoration of IGF-I levels in aging by dehydroepiandrosterone
|
|
ES2176252T3
(es)
*
|
1993-07-02 |
2002-12-01 |
Altana Pharma Ag |
Benzamidas sustituidas con fluoro-alcoxi y su utilizacion como agentes inhibidores de fosfodiesterasas de nucleotidos ciclicos.
|
|
HUT77514A
(hu)
*
|
1994-11-30 |
1998-05-28 |
Amur Research Corp. |
Gyógyszerhatóanyagok foszfokolinszármazékai
|
|
US20020032160A1
(en)
*
|
1995-02-24 |
2002-03-14 |
Nyce Jonathan W. |
Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
|
|
US5660835A
(en)
*
|
1995-02-24 |
1997-08-26 |
East Carolina University |
Method of treating adenosine depletion
|
|
US5859000A
(en)
*
|
1995-06-07 |
1999-01-12 |
University Of Utah Research Foundation |
Method for reducing mast cell mediated allergic reactions
|
|
US5767278A
(en)
*
|
1995-10-06 |
1998-06-16 |
Geron Corporation |
Telomerase inhibitors
|
|
EP1806131A3
(en)
*
|
1996-07-22 |
2007-08-01 |
Renovo Limited |
Use of sex steroid function modulators to treat wounds and fibrotic disorders
|
|
US5861391A
(en)
*
|
1997-01-29 |
1999-01-19 |
Research Development Foundation |
Use of dehydroepiandrosterone to treat primary adrenal insufficiency and Addison's disease
|
|
US20030013772A1
(en)
*
|
2000-02-23 |
2003-01-16 |
Murphy Michael A. |
Composition, synthesis and therapeutic applications of polyamines
|
|
AU763307B2
(en)
*
|
1998-02-04 |
2003-07-17 |
Charlotte-Mecklenburg Hospital Authority |
Androsterone derivatives for inhibiting DNA binding of AP-1 and airway smooth muscle proliferation
|
|
CA2389293A1
(en)
*
|
1999-10-29 |
2001-05-10 |
Smithkline Beecham Corporation |
Method for administering a phosphodiesterase 4 inhibitor
|
|
AR029189A1
(es)
*
|
1999-11-02 |
2003-06-18 |
Smithkline Beecham Corp |
Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento
|
|
JP2004502643A
(ja)
*
|
2000-02-16 |
2004-01-29 |
ユニバーシティ・オブ・ネブラスカ・メディカル・センター |
線維症性疾患の治療法および治療用組成物
|
|
EP1161949A1
(en)
*
|
2000-06-09 |
2001-12-12 |
Warner-Lambert Company |
Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease
|
|
US7381713B2
(en)
*
|
2000-12-04 |
2008-06-03 |
Sioan-Kettering Institute For Cancer Research |
Treatment of cancer by reduction of intracellular energy and pyrimidines
|
|
AU2002303427A1
(en)
*
|
2001-04-24 |
2002-11-05 |
East Carolina University |
Compositions and formulations with a non-glucocorticoid steroid and/or a ubiquinone and kit for treatment of respiratory and lung disease
|
|
US20030216329A1
(en)
*
|
2001-04-24 |
2003-11-20 |
Robinson Cynthia B. |
Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s)
|
|
AU2002303425A1
(en)
*
|
2001-04-24 |
2002-11-05 |
Epigenesis Pharmaceuticals, Inc. |
Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
|
|
GB0115181D0
(en)
*
|
2001-06-20 |
2001-08-15 |
Glaxo Group Ltd |
Novel use
|
|
GB0118373D0
(en)
*
|
2001-07-27 |
2001-09-19 |
Glaxo Group Ltd |
Novel therapeutic method
|
|
US20030138434A1
(en)
*
|
2001-08-13 |
2003-07-24 |
Campbell Robert L. |
Agents for enhancing the immune response
|
|
GB0123951D0
(en)
*
|
2001-10-05 |
2001-11-28 |
Glaxo Group Ltd |
Therapies for treating respiratory diseases
|
|
FR2834212B1
(fr)
*
|
2001-12-27 |
2004-07-09 |
Besins Int Belgique |
Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
|
|
US20050026886A1
(en)
*
|
2003-07-29 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
|